Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Figure out How to Reveal Stowed away Open Record Rewards - 2Find the Historical backdrop of the Modern Unrest: Changing Society and Innovation
- 3Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer's trials
- 4US FDA declines to approve Corcept's drug for rare hormonal disorder
- 5The Best Internet based Retailers for Style and Frill
- Winter virus season so far is not too bad, but doctors worry about suffering to come
- Consumer outlook on UK economy falls to two-year low
- If you want a true taste of Italian paradise, head to Favignana
- Eco-Accommodating Kitchen Machines: 4 Picks for a Manageable Home
- Air travelers face higher ticket prices as Iran war drives up oil prices
- Was This Driver Simply Having Some good times Or Behaving Like An Ass?
- Overhaul Your Rest: Tips for a Serene Evening
- Vaccine exemptions for religious or personal beliefs are rising across the U.S.
- IDF says up to 90% of Iran’s weapons industry could be hit within days
